Syndeio Biosciences News and Activities

Acquisition, funding and merger involving Syndeio Biosciences.

• Syndeio Biosciences has just announced a $90 Million fundraising (posted on May 28 2025).

View the org chart displaying its 12 main executives

Most searched biographies at Syndeio Biosciences

• Derek Small, Chief Executive Officer
• Pavel Raifeld, Director
• Jacob Vogelstein, Director

Popular executive movements at Syndeio Biosciences

• Aaron Koenig has joined the company as Chief Medical Officer  (posted on November 5 2025).

Create your alert
to follow the executive moves at Syndeio Biosciences.

Syndeio Biosciences has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Syndeio Biosciences

• Syndeio Biosciences Appoints Aaron Koenig, M.D., as Chief Medical Officer — Syndeio Biosciences

Social media about Syndeio Biosciences

• Syndeio Biosciences on Wikipedia, Google News & Yahoo Finance
• Syndeio Biosciences on LinkedIn, X (Twitter) & YouTube